KOLOA, Hawaii — An artificial intelligence-driven algorithm may help predict the progression of intermediate age-related macular degeneration to geographic atrophy, according to a speaker.
“We all understand ... what a huge unmet clinical need geographic atrophy is,” Eleonora Lad, MD, PhD, said at Retina 2023. “To date, no treatment has been approved to either reverse or prevent its progression.”
There is currently an incomplete understanding of the pathogenesis and progression of nonexudative AMD, as well as what the best endpoints for clinical trials are and who